Lv1
50 积分 2023-11-09 加入
Combination of daratumumab, ixazomib, and lenalidomide with or without dexamethasone for initial therapy of newly diagnosed myeloma
2个月前
已完结
[Guidelines for the diagnosis and management of multiple myeloma in China (2024 revision)]
3个月前
已完结
[China lymphoma diagnosis and treatment guideline (2026 edition)]
3个月前
已完结
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR
7个月前
已关闭
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
7个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
7个月前
已关闭
The role of allogeneic stem cell transplantation in acute myeloid leukemia. Who, when and what type of conditioning?
7个月前
已完结
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
7个月前
已完结
皖公网安备34019202002308
